A RESPONSE to ruxolitinib: update on 4-year trial follow-up
Jean-Jacques Kiladjian • 2 Mar 2018
CAR T-cell therapy: a new outlook for older patients with aggressive lymphomas?
Raúl Córdoba • 21 Dec 2018
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.